Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator.
J Biol Chem
; 286(45): 39247-58, 2011 Nov 11.
Article
in En
| MEDLINE
| ID: mdl-21917926
Full text:
1
Database:
MEDLINE
Main subject:
Sulfonamides
/
Breast Neoplasms
/
Signal Transduction
/
Enzyme Activators
/
Thiazolidinediones
/
AMP-Activated Protein Kinases
/
Neoplasm Proteins
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Biol Chem
Year:
2011
Type:
Article
Affiliation country:
United States